Chronic liver diseases, such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), are leading causes of morbidity and mortality in the United States. PBC and NASH differ with respect to their epidemiology, presentation, management options, and response to treatment. The burden of these diseases is considerable; however, management strategies of PBC and NASH have advanced in recent years due to an increased understanding of the pathophysiologic mechanisms of each disease and potential targets for therapy. This program will provide expert insight into unmet needs in PBC and NASH and how novel therapeutic approaches may help overcome existing challenges in disease management and improve patient outcomes.
This webcast is based on the live symposium held in Boston, MA, presented for attendees of the 65th AASLD Annual Meeting (The Liver Meeting®). This is not an official event/function of the American Association for the Study of Liver Diseases.